Table 3

Clinical Outcomes at 30 Days and 1 Year

TAXUS StentControl StentTAXUS vs. Control
WomenMenp ValueWomenMenp ValueWomen p ValueMen p Value
n187475180472
30 days, %
 Major adverse cardiac events2.13.20.483.32.10.370.480.32
 Cardiac death0.00.40.370.00.60.280.65
 Myocardial infarction2.12.70.663.31.90.280.480.39
 Target vessel revascularization0.00.00.00.40.380.16
 Stent thrombosis0.00.40.370.00.80.220.41
1 year, %
 Major adverse cardiac events13.59.90.2422.719.00.350.02<0.0001
 Target vessel failure13.08.80.1521.618.60.450.03<0.0001
 Cardiac death0.51.70.251.81.10.530.300.41
 Myocardial infarction2.73.80.487.93.40.020.030.73
 Target lesion revascularization7.63.20.0314.915.20.880.02<0.0001
 Target vessel revascularization10.85.70.0317.517.00.950.07<0.0001
  Repeat coronary intervention9.24.10.0215.213.40.690.08<0.0001
  Bypass graft surgery2.21.60.542.24.70.150.950.0044
 Stent thrombosis0.00.80.210.01.10.170.73